ASEAN: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in ASEAN

The ASEAN prophylactic medicaments containing insulin market amounted to $X in 2022, remaining relatively unchanged against the previous year. Over the period under review, consumption, however, posted a prominent increase. Over the period under review, the market attained the peak level at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in ASEAN

In value terms, prophylactic medicaments containing insulin production expanded to $X in 2022 estimated in export price. Overall, production, however, recorded a buoyant increase. The growth pace was the most rapid in 2017 when the production volume increased by 65% against the previous year. The level of production peaked at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in ASEAN

After ten years of growth, shipments abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -12.5% to X tons in 2022. Overall, exports, however, enjoyed a significant expansion. The most prominent rate of growth was recorded in 2013 when exports increased by 232% against the previous year. The volume of export peaked at X tons in 2021, and then reduced in the following year.

In value terms, prophylactic medicaments containing insulin exports contracted significantly to $X in 2022. In general, exports, however, recorded significant growth. The most prominent rate of growth was recorded in 2020 with an increase of 267%. The level of export peaked at $X in 2021, and then reduced markedly in the following year.

Exports by Country

Malaysia represented the largest exporter of medicaments containing insulin but not antibiotics in measured doses in ASEAN, with the volume of exports amounting to X tons, which was approx. 60% of total exports in 2022. It was distantly followed by Singapore (X tons), constituting a 39% share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the leading exporting countries, was attained by Singapore (with a CAGR of +173.5%).

In value terms, Malaysia ($X) and Singapore ($X) appeared to be the countries with the highest levels of exports in 2022.

Singapore, with a CAGR of +183.0%, saw the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review.

Export Prices by Country

The export price in ASEAN stood at $X per ton in 2022, which is down by -5.2% against the previous year. Overall, the export price, however, recorded modest growth. The pace of growth was the most pronounced in 2019 an increase of 73%. The level of export peaked at $X per ton in 2021, and then reduced in the following year.

Average prices varied noticeably amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Malaysia ($X per ton), while Singapore amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Singapore (+3.5%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in ASEAN

For the fifth consecutive year, ASEAN recorded growth in purchases abroad of medicaments containing insulin but not antibiotics in measured doses, which increased by 9.8% to X tons in 2022. In general, imports enjoyed a remarkable increase. The pace of growth was the most pronounced in 2016 when imports increased by 37%. The volume of import peaked in 2022 and is likely to see steady growth in years to come.

In value terms, prophylactic medicaments containing insulin imports rose modestly to $X in 2022. Over the period under review, imports showed a strong expansion. The pace of growth appeared the most rapid in 2014 with an increase of 28%. The level of import peaked in 2022 and is expected to retain growth in the immediate term.

Imports by Country

Indonesia (X tons), Thailand (X tons), the Philippines (X tons), Vietnam (X tons) and Singapore (X tons) represented roughly 93% of total imports in 2022. It was distantly followed by Malaysia (X tons), comprising a 6% share of total imports.

From 2012 to 2022, the biggest increases were recorded for Singapore (with a CAGR of +33.9%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Vietnam ($X), Indonesia ($X) and Singapore ($X) were the countries with the highest levels of imports in 2022, together comprising 66% of total imports.

Singapore, with a CAGR of +29.9%, recorded the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in ASEAN amounted to $X per ton, reducing by -4.5% against the previous year. In general, the import price showed a slight curtailment. The pace of growth was the most pronounced in 2018 when the import price increased by 9% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Vietnam ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Vietnam (-0.7%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform